6533b82bfe1ef96bd128d8be

RESEARCH PRODUCT

Real-Life Outcomes of Coronary Bifurcation Stenting in Acute Myocardial Infarction (Zabrze–Opole Registry)

Piotr MuzykWojciech MilejskiJerzy SachaPiotr FeusetteAndrzej TomasikDamian KaweckiBeata MorawiecMarek GierlotkaMarek Cisowski

subject

Target lesionmedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionCulpritArticlemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemPharmacology (medical)cardiovascular diseasesMyocardial infarctionGeneral Pharmacology Toxicology and PharmaceuticsRisk factoracute myocardial infarction; coronary bifurcation; percutaneous coronary intervention; target lesion failureAdverse effectcoronary bifurcationbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseRC666-701Right coronary arteryConventional PCICardiologytarget lesion failurebusiness

description

Percutaneous coronary intervention (PCI) of bifurcation lesions is a technical challenge associated with high risk of adverse events, especially in primary PCI. The aim of the study is to analyze long-term outcomes after PCI for coronary bifurcation in acute myocardial infarction (AMI). The outcome was defined as the rate of major adverse cardiac event related to target lesion failure (MACE-TLF) (death-TLF, nonfatal myocardial infarction-TLF and target lesion revascularization (TLR)) and the rate of stent thrombosis (ST). From 306 patients enrolled to the registry, 113 were diagnosed with AMI. In the long term, AMI was not a risk factor for MACE-TLF. The risk of MACE-TLF was dependent on the culprit lesion, especially in the right coronary artery (RCA) and side branch (SB) with a diameter &gt

yearjournalcountryeditionlanguage
2021-11-11Journal of Cardiovascular Development and Disease
10.3390/jcdd8110155https://www.mdpi.com/2308-3425/8/11/155